May 20 Respiratory drugs specialist Vectura Group Plc reported a bigger-than-expected jump in full-year revenue as it raked in higher royalty payments and licensing revenue.
The company, which develops and markets drugs for illnesses such as asthma and chronic obstructive pulmonary disease, said revenue rose to 58 million pounds ($89.8 million) in the year ended March 31 from 36.5 million pounds a year earlier.
06:04 Los Angeles Angels OF Kole Calhoun gets 3-year extension17
23:10 Tim Raines, Jeff Bagwell, Pudge Rodriguez elected to Baseball Hall of Fame16
11:20 PE firm Warburg buys $121 million stake in Indian cinema operator PVR13
20:41 Jose Bautista to re-sign with Blue Jays with one-year deal8